| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.09 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.061 | 0.09 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.073 | 0.09 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.081 | 0.1 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |